Delivery Order SPE2DB24D2205-SPE2DB24FEANC

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ropinirole hydrochloride extended-release 2 mg tablets. The $1,668.36 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense that provides logistics, contracting, and military supply chain management services. The contract has an ultimate completion date of December 17, 2024, and is part of a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ropinirole hydrochloride extended-release 2 mg tablets in 30-count packages. The $7,780.64 contract supports medical supply needs for the DLA Troop Support Medical program, which provides pharmaceutical and medical products to military treatment facilities, veterans' healthcare, and other federal medical institutions....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.56 firm-fixed-price delivery order is for the supply of 4,566,267,136 units of the prescription medication Ropinirole HCl ER 2 mg Tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ropinirole hydrochloride extended-release 2 mg tablets. The order, valued at $1,149.62, is a firm fixed-price contract with a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, is known for providing a wide range of medical products and supplies to various federal agencies and healthcare programs. This contract represents part of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 12 mg tablets, with a ceiling value of $1,536.03 and a completion date of January 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 90 tablets of Ropinirole Hydrochloride Extended Release 2 mg, a pharmaceutical product, with a potential value of $4,787.32. The delivery order was issued on January 4, 2024, with a completion date of January 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,373.64 Firm Fixed Price delivery order is for the supply of Ropinirole HCL ER 6 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,025.74 Firm Fixed Price contract is for the delivery of 4565441737 - Ropinirole HCL ER 12 mg Tablet 30s. The contract does not have a set-aside designation and is expected to be completed by August 14, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,417.92 Firm Fixed Price Delivery Order is for the supply of 4556709390 - Ropinirole HCl Extended Release 8 mg Tablets, with a completion date of March 29, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FEANC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ropinirole hydrochloride extended-release 6 mg tablets. The firm-fixed-price delivery order, valued at $1,260.55, has a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/26/24, 9:28 AM